Last updated 9 days ago

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

636 patients around the world
Available in Chile, Puerto Rico, United States, Spain, Guatemala
Merck Sharp & Dohme LLC
10Research sites
636Patients around the world
This study is for people with
Bladder Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro Oncológico del Norte - Antofagasta
Centro Oncológico del Norte - Antofagasta
Recruiting
Los Pumas 10255. Chimba Alto, Antofagasta
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
Manzano 343, Recoleta, Región Metropolitana, Santiago
Instituto Oncológico FALP (Fundación Arturo Lopez Perez)
Recruiting
José Manuel Infante 805, Providencia, Región Metropolitana, Santiago
Oncocentro APYS - Valparaíso
Recruiting
Avenida La Marina 1702, Viña del Mar, Valparaíso
Centro Medico Integral de Cancerología CEMIC - Guatemala
Recruiting
Km. 194 Carretera Interamericana Z.0, Salcaja, Quetzaltenango
Oncomedica-Guatemala
Recruiting
Guatemala, 01010
Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN
Recruiting
Guatemala, 01010
Grupo Medico Angeles, Dr Hugo Castro
Recruiting
Edificio Multimédica, 2da calle 25-19 zona 15 Vista Hermosa I, Edif, 10-15, Cdad. de Guatemala 01015
Medi-K Cayala
Recruiting
Boulevard Austríaco Zona 16, Ciudad Cayalá Edificio P4,3er. Nivel. Parqueo J Ciudad de Guatemala, 01016, Guatemala
Pan American Center for Oncology Trials
Recruiting
PO Box 9022971 SAN JUAN, PR 00902
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy